76Bio, Inc.
PrivateLast Round
Series A
Feb 6, 2023
Total Funding Raised
$22.2M
Company Overview
76Bio, Inc. is a biotechnology company founded in 2020 and headquartered in Boston, MA. The company is developing a platform for targeted protein degradation, aiming to create therapies for life-threatening diseases by breaking down unneeded proteins. It operates in the drug discovery and biotechnology sectors. The company is venture capital-backed, having raised $22.2M in funding, including a $12.2M early-stage VC round in February 2023.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
76Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
76Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 6, 2023 | ||||
| Seed | Jan 7, 2022 |
76Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Two River Group | Series A, Seed |
| Sonostar Ventures | Series A, Seed |
| Polaris Partners | Series A, Seed |
76Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 76Bio, Inc.'s valuation, stock price, and market status.
